IL154128A0 - Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents - Google Patents

Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents

Info

Publication number
IL154128A0
IL154128A0 IL15412801A IL15412801A IL154128A0 IL 154128 A0 IL154128 A0 IL 154128A0 IL 15412801 A IL15412801 A IL 15412801A IL 15412801 A IL15412801 A IL 15412801A IL 154128 A0 IL154128 A0 IL 154128A0
Authority
IL
Israel
Prior art keywords
screening
methods
active agents
pharmaceutically active
genes encoding
Prior art date
Application number
IL15412801A
Other languages
English (en)
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of IL154128A0 publication Critical patent/IL154128A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1086—Preparation or screening of expression libraries, e.g. reporter assays
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1034—Isolating an individual clone by screening libraries
    • C12N15/1051—Gene trapping, e.g. exon-, intron-, IRES-, signal sequence-trap cloning, trap vectors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5076—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving cell organelles, e.g. Golgi complex, endoplasmic reticulum

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Biophysics (AREA)
  • Hematology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Toxicology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
IL15412801A 2000-08-29 2001-08-29 Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents IL154128A0 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US22842000P 2000-08-29 2000-08-29
US30645701P 2001-07-20 2001-07-20
PCT/IL2001/000813 WO2002018537A2 (fr) 2000-08-29 2001-08-29 Methodes d'isolation de genes codant des proteines a fonction specifique et de criblage d'agents actifs d'un point de vue pharmaceutique

Publications (1)

Publication Number Publication Date
IL154128A0 true IL154128A0 (en) 2003-07-31

Family

ID=26922359

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15412801A IL154128A0 (en) 2000-08-29 2001-08-29 Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents

Country Status (7)

Country Link
US (1) US20060240404A1 (fr)
EP (1) EP1313883A4 (fr)
JP (1) JP2004520014A (fr)
AU (1) AU2001284373A1 (fr)
CA (1) CA2417233A1 (fr)
IL (1) IL154128A0 (fr)
WO (1) WO2002018537A2 (fr)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8131053B2 (en) 1999-01-25 2012-03-06 Amnis Corporation Detection of circulating tumor cells using imaging flow cytometry
US7450229B2 (en) 1999-01-25 2008-11-11 Amnis Corporation Methods for analyzing inter-cellular phenomena
US8885913B2 (en) 1999-01-25 2014-11-11 Amnis Corporation Detection of circulating tumor cells using imaging flow cytometry
US8406498B2 (en) 1999-01-25 2013-03-26 Amnis Corporation Blood and cell analysis using an imaging flow cytometer
US7907765B2 (en) 2001-03-28 2011-03-15 University Of Washington Focal plane tracking for optical microtomography
US6636623B2 (en) * 2001-08-10 2003-10-21 Visiongate, Inc. Optical projection imaging system and method for automatically detecting cells with molecular marker compartmentalization associated with malignancy and disease
US7738945B2 (en) 2002-04-19 2010-06-15 University Of Washington Method and apparatus for pseudo-projection formation for optical tomography
US7260253B2 (en) 2002-04-19 2007-08-21 Visiongate, Inc. Method for correction of relative object-detector motion between successive views
US8150136B2 (en) 2004-03-16 2012-04-03 Amnis Corporation Image based quantitation of molecular translocation
US8953866B2 (en) 2004-03-16 2015-02-10 Amnis Corporation Method for imaging and differential analysis of cells
US7630849B2 (en) * 2005-09-01 2009-12-08 Applied Biosystems, Llc Method of automated calibration and diagnosis of laboratory instruments
US8114615B2 (en) 2006-05-17 2012-02-14 Cernostics, Inc. Method for automated tissue analysis
US20100112602A1 (en) * 2006-11-10 2010-05-06 Taylor Lansing D Protein-Protein Interaction Biosensors and Methods of Use Thereof
US7835561B2 (en) 2007-05-18 2010-11-16 Visiongate, Inc. Method for image processing and reconstruction of images for optical tomography
US7787112B2 (en) 2007-10-22 2010-08-31 Visiongate, Inc. Depth of field extension for optical tomography
WO2011138778A2 (fr) 2010-05-04 2011-11-10 Yissum Research Development Company Of The Hebrew University Of Jerusalem Ltd. Procédés permettant d'identifier des inhibiteurs de polypeptides d'intérêt
AU2012229102B2 (en) 2011-03-17 2016-02-04 Cernostics, Inc. Systems and compositions for diagnosing Barrett's esophagus and methods of using the same
US11069054B2 (en) 2015-12-30 2021-07-20 Visiongate, Inc. System and method for automated detection and monitoring of dysplasia and administration of immunotherapy and chemotherapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5639949A (en) * 1990-08-20 1997-06-17 Ciba-Geigy Corporation Genes for the synthesis of antipathogenic substances
US6054312A (en) * 1997-08-29 2000-04-25 Selective Genetics, Inc. Receptor-mediated gene delivery using bacteriophage vectors
WO1999055886A1 (fr) * 1998-04-24 1999-11-04 Genova Pharmaceuticals Corporation Decouverte de genes fonctionnels
JP2003509060A (ja) * 1999-09-17 2003-03-11 ホワイトヘッド・インスティテュート・フォー・バイオメディカル・リサーチ 逆トランスフェクション方法

Also Published As

Publication number Publication date
AU2001284373A1 (en) 2002-03-13
EP1313883A2 (fr) 2003-05-28
US20060240404A1 (en) 2006-10-26
WO2002018537A3 (fr) 2002-07-25
CA2417233A1 (fr) 2002-03-07
JP2004520014A (ja) 2004-07-08
EP1313883A4 (fr) 2005-01-12
WO2002018537A2 (fr) 2002-03-07

Similar Documents

Publication Publication Date Title
IL153970A0 (en) Promyostatin peptides and methods of using same
IL154128A0 (en) Methods of isolating genes encoding proteins of specific function and of screening for pharmaceutically active agents
EP1435911A4 (fr) Dispositifs a base de matrices proteiques et procedes de fabrication et d'utilisation associes
AU4907901A (en) Protein matrix materials, devices and methods of making and using thereof
AU7593001A (en) Alpha-msh related compounds and methods of use
IL137445A0 (en) Pharmaceutically active compounds and methods of use thereof
AU2001277172A1 (en) Bstp-trans protein and related reagents and methods of use thereof
AU1194802A (en) DNA expression vectors and methods of use
EP1265913A4 (fr) Caracterisation d'interactions ligands-grp94 et methodes de purification, de criblage et de traitement associees
EP1165586A4 (fr) GENE TCL-1b ET PROTEINE, PROCEDES ET COMPOSITIONS S'Y RAPPORTANT
EP1183030A4 (fr) Procede de fabrication et d'application de n-desmethylzopiclone
HK1053673A1 (zh) 使蛋白不穩定的方法及其用途
AU2001271502A1 (en) Methods and compositions for isolating biologically active antibodies
EP1115396A4 (fr) Composes pharmaceutiquement actifs, et methodes d'utilisation correspondantes
AU2001273074A1 (en) Combinations of ssri and estrogenic agents
IL142469A0 (en) Methods and reagents for isolating biologically active peptides
EP1154997A4 (fr) Composes pharmaceutiquement actifs et procedes d'utilisation
IL146449A0 (en) Method and pharmaceutical preparations for reducing the activity of cells
IL154357A0 (en) Stress proteins and peptides and methods of use thereof
HK1047673B (zh) 蜂窩系統虛擬漫游及互通的實現方法與系統
EP1194548A4 (fr) Nouveaux peptides derives de pyrrhocoricine et leurs procedes de mise en application
EP1263935A4 (fr) Scytonemine et ses procedes d'utilisation
AU2001284651A1 (en) Secreted proteins and methods of using same
AUPQ599500A0 (en) Novel peptides, modulatory agents therefor and methods of using them
EP1305008A4 (fr) Formes ameliorees d'agents pharmaceutiquement actifs et procede de fabrication de celles-ci